Myrianni Constantinou

Myrianni Constantinou is a scientist with a background in cancer genomics, holding a Ph.D. from Queen Mary University of London, where studies were completed between 2019 and 2023. Prior to that, Myrianni obtained a Master of Research (MRes) in Cellular and Molecular Neuro-oncology from the University of Portsmouth in 2017. Myrianni has extensive research experience, including roles as a postdoctoral researcher at the Blizard Institute and a visiting researcher at the University of Portsmouth. Additional positions include volunteer research assistant and student ambassador, demonstrating a strong commitment to academic and community engagement. Currently, Myrianni works as a scientist at Kesmalea Therapeutics.